LifeVantage Presenting at Experimental Biology Annual Meeting
March 31 2015 - 9:00AM
LifeVantage Corporation (Nasdaq:LFVN), has announced that Vice
President of Product Development Nathalie Chevreau, PhD is
presenting a poster abstract at the Experimental Biology 2015
Boston meeting. The poster highlights a portion of the findings
from clinical research being conducted by LifeVantage on its Canine
Health product, a Nrf2 Synergizer for dogs.
The findings from the research show a decrease in oxidative
stress in dogs that have taken Canine Health over a period of 60
days. The studies also demonstrate improved physical performance in
the dogs taking Canine Health. These improvements include greater
mobility, faster running times, decreased stiffness, and increased
energy levels when compared to dogs taking a placebo.
"Experimental Biology is the largest gathering of lifestyle
scientists in the world, so we are honored that LifeVantage is
invited to present our research to such a prestigious audience,"
said LifeVantage Chief Science Officer, Shawn Talbott, PhD. "These
results demonstrate the ability of Canine Health to reduce cellular
stress and improve the quality of life in older dogs- which is
something that all 'dog parents' want for their best friends."
Experimental Biology is an annual meeting comprised of more than
14,000 research scientists whose fields of study include anatomy,
physiology, pathology, biochemistry, nutrition, and
pharmacology.
About LifeVantage Corporation
LifeVantage Corporation (Nasdaq:LFVN), is a science based
network marketing company dedicated to visionary science that looks
to transform health, wellness and anti-aging internally and
externally at the cellular level. The company is the maker of
Protandim®, the Nrf2 Synergizer® patented dietary supplement, the
TrueScience™ Anti-Aging Skin Care Regimen, Canine Health, and the
AXIO™ energy product line. LifeVantage was founded in 2003
and is headquartered in Salt Lake City, Utah.
CONTACT: Company Relations Contact:
John Genna (801) 432-9172
Vice President of Communications &
Corporate Partnerships
Investor Relations Contact:
Cindy England (801) 432-9036
Director of Investor Relations
-or-
John Mills (646) 277-1254
Partner, ICR INC
Lifevantage (NASDAQ:LFVN)
Historical Stock Chart
From Mar 2024 to Apr 2024
Lifevantage (NASDAQ:LFVN)
Historical Stock Chart
From Apr 2023 to Apr 2024